Editorial: Utilization of pharmacogenomics in clinical practice
- PMID: 39228415
- PMCID: PMC11368833
- DOI: 10.3389/fgene.2024.1470698
Editorial: Utilization of pharmacogenomics in clinical practice
Keywords: adverse drug (event); clinical practice; drug efficacy and safety; genomic education; pharmacogenomic (PGx) research; pharmacology.
Conflict of interest statement
Author AP was employed by AstraZeneca. Author SN was employed by Phytoveda Pvt. Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Utilization of pharmacogenomics in clinical practice
Publication types
LinkOut - more resources
Full Text Sources
